Laurence Amar

Active 1986–2025

110
Papers
18,102
Citations
70
h-index
107
i10-index

Citations

Citations per year for Laurence Amar1986: 1 citations1987: 9 citations1988: 8 citations1989: 9 citations1990: 13 citations1991: 7 citations1992: 7 citations1993: 8 citations1994: 4 citations1995: 1 citations1996: 3 citations1997: 2 citations1998: 1 citations1999: 1 citations2000: 1 citations2001: 1 citations2002: 1 citations2003: 2 citations2004: 1 citations2005: 12 citations2006: 12 citations2007: 21 citations2008: 22 citations2009: 46 citations2010: 70 citations2011: 65 citations2012: 107 citations2013: 135 citations2014: 176 citations2015: 181 citations2016: 138 citations2017: 226 citations2018: 159 citations2019: 731 citations2020: 750 citations2021: 652 citations2022: 564 citations2023: 397 citations2024: 688 citations2025: 307 citations2026: 16 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,122 citing papers, 20.1% of this breakdownGermany: 448 citing papers, 8% of this breakdownItaly: 411 citing papers, 7.4% of this breakdownFrance: 390 citing papers, 7% of this breakdownUnited Kingdom: 355 citing papers, 6.3% of this breakdownChina: 309 citing papers, 5.5% of this breakdownNetherlands: 277 citing papers, 5% of this breakdownAustralia: 213 citing papers, 3.8% of this breakdownJapan: 190 citing papers, 3.4% of this breakdownSpain: 177 citing papers, 3.2% of this breakdownCanada: 166 citing papers, 3% of this breakdownSwitzerland: 148 citing papers, 2.6% of this breakdown
0%20.1%Other 24.7%

Fields

  • Medicine73.1%
  • Biochemistry, Genetics and Molecular Biology23.4%
  • Neuroscience1.5%
  • Immunology and Microbiology0.5%
  • Engineering0.3%
  • Chemistry0.2%
  • Other1%

Topics

  • Adrenal and Paraganglionic Tumors16%
  • Hormonal Regulation and Hypertension13.8%
  • Cancer, Hypoxia, and Metabolism8.5%
  • Pituitary Gland Disorders and Treatments5.6%
  • Adrenal Hormones and Disorders4.3%
  • Renin-Angiotensin System Studies2.9%
  • Other48.9%

Coauthors

All papers

Open in search
  1. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard J. Auchus, Detlef K. Bartsch, René Baudrand, Felix Beuschlein, Peyman Björklund, Morris J. Brown, Jacopo Burrello, Robert M. Carey, Cristiana Catena, John Connell, Jaap Deinum, Tanja Dekkers, Thomas J. Fahey, Francesco Fallo, Carlos Fardella, Gilberta Giacchetti, Giuseppe Giraudo, Per Hellman, Andrzej Januszewicz, Kanako Kiriyama Kitamoto, Gregory Kline, Tomaž Kocjan, Jacques W.M. Lenders, Franco Mantero, Barbra S. Miller, Ryo Morimoto, Paolo Mulatero, Mitsuhide Naruse, Tetsuo Nishikawa, Uyen Thi Phuong Pham, Pierre‐François Plouin, Alexander Prejbisz, Marcus Quinkler, Marietta Rottenkolber, Christian L Rump, Fumitoshi Satoh, Leonardo A. Sechi, Michael Stowasser, Hironobu Umakoshi, Franco Veglio, J Widimský, Holger S. Willenberg, William F. Young - The Lancet Diabetes & Endocrinology 2017 cited by 945

  2. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L. Sylvia, Richard J. Auchus, J. Todd Auman, Robert Baertsch, Miruna Balasundaram, Saianand Balu, Detlef K. Bartsch, Éric Baudin, Thomas Bauer, Allison Beaver, Christopher C. Benz, Rameen Beroukhim, Felix Beuschlein, Tom Bodenheimer, Lori Boice, Jay Bowen, Reanne Bowlby, Denise Brooks, Rebecca Carlsen, Suzie Carter, Clarissa A. Cassol, Andrew D. Cherniack, Lynda Chin, Juok Cho, Eric Chuah, Sudha Chudamani, Leslie Cope, Daniel Crain, Erin Curley, Ludmila Danilova, Aguirre A. de Cubas, Ronald R. de Krijger, John A. Demchok, Timo Deutschbein, Noreen Dhalla, David Dimmock, Winand N.M. Dinjens, Tobias Else, Charis Eng, Jennifer Eschbacher, Martin Faßnacht, Ina Felau, Michael D. Feldman, Martin L. Ferguson, Ian T. Fiddes, Lauren Fishbein, Scott Frazer, Stacey Gabriel, Johanna Gardner, Julie M. Gastier‐Foster, Nils Gehlenborg, Mark Gerken, Gad Getz, Jennifer L. Geurts, Hans K. Ghayee, Anne‐Paule Gimenez‐Roqueplo, Thomas J. Giordano, Mary J. Goldman, Kiley Graim, Manaswi Gupta, David Haan, Stefanie Hahner, Constanze Hantel, David Haussler, D. Neil Hayes, David I. Heiman, Katherine A. Hoadley, Robert A. Holt, Alan P. Hoyle, Mei Huang and 132 more - Cancer Cell 2017 cited by 783

  3. SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma

    Authors: , , , , , , , , , , , , , , , , , - Cancer Cell 2013 cited by 768

  4. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension ∗

    Authors: , , , , , , , , , , , , , - Journal of Hypertension 2020 cited by 307

  5. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension

    Authors: , , , , , , , , , , , , , , , , - Journal of Hypertension 2020 cited by 395

  6. Adrenergic receptors and cardiovascular effects of catecholamines

    Authors: , , - Annales d Endocrinologie 2020 cited by 280

  7. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Endocrinology 2021 cited by 163

  8. Integrated genomic characterization of adrenocortical carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Felix Beuschlein, Rossella Libé, Aurélien de Reyniès, Jérôme Bertherat - Nature Genetics 2014 cited by 733

  9. Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas

    Authors: , , , , , , , , , , , , , , , , , , , , , - Human Molecular Genetics 2013 cited by 391

  10. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma

    Authors: , , , , , , , , _ _ - European Journal of Endocrinology 2016 cited by 466

  11. Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabelle Borget, Éric Baudin, European Network for the Study of Adrenal Tumors (ENS@T) - The Journal of Clinical Endocrinology & Metabolism 2019 cited by 180

  12. Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Cole, Isabella Sudano, Cornelia Prehn, Jerzy Adamski, Anne‐Paule Gimenez‐Roqueplo, Guillaume Assié, Wiebke Arlt, Felix Beuschlein, Graeme Eisenhofer, Eleanor Davies, Maria‐Christina Zennaro, Emily Jefferson - EBioMedicine 2022 cited by 89

  13. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eamonn R. Maher, Daniele Marchioni, Leilani B Mercado-Asis, Özgür Mete, Mitsuhide Naruse, Naris Nilubol, Neeta Pandit‐Taskar, F. Sébag, Akiyo Tanabe, J Widimský, Leah Meuter, Jacques W.M. Lenders, Karel Pacák - The Lancet Diabetes & Endocrinology 2023 cited by 87

  14. Cardiovascular Complications Associated With Primary Aldosteronism

    Authors: , , , - Hypertension 2013 cited by 506

  15. MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacques W.M. Lenders, Rocío Letón, Arjen R. Mensenkamp, Anna Merlo, Luigi Mori, Arnaud Murat, P. Pierre, Pierre‐François Plouin, Tamara Prodanov, Miguel Quesada‐Charneco, Nan Qin, Elena Rapizzi, Victoria M. Raymond, Nicole Reisch, Giovanna Roncador, Macarena Ruiz‐Ferrer, F. Schillo, Alexander P.A. Stegmann, Carlos Suárez, Elisa Taschin, Henri Timmers, Carli M.J. Tops, Miguel Urioste, Felix Beuschlein, Karel Pacák, Massimo Mannelli, Patricia L. M. Dahia, Giuseppe Opocher, Graeme Eisenhofer, Anne‐Paule Gimenez‐Roqueplo, Mercedes Robledo - Clinical Cancer Research 2012 cited by 327

  16. Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frédéric Castinetti, Jérôme Bertherat, Rossella Libé, Anne‐Paule Gimenez‐Roqueplo, Judith Favier, Marcus Quinkler, Christian J. Strasburger, Katrin Zopf, Martín Reincke, Matthias Kroiß, Hanna Remde, Michaela Haaf, Carmina Teresa Fuß, Ulrich Dischinger, Graeme Eisenhofer, Christina Pamporaki, Anouk van Berkel - The Lancet 2024 cited by 66

  17. The Adrenal Vein Sampling International Study (AVIS) for Identifying the Major Subtypes of Primary Aldosteronism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oliver Vonend, J Widimský, Kwan‐Dun Wu, Vin‐Cent Wu, Achille C. Pessina - The Journal of Clinical Endocrinology & Metabolism 2012 cited by 372

  18. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma

    Authors: , , , , , , , , , , , , , , , , , , , - International Journal of Cancer 2014 cited by 204

  19. Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giulio Barbiero, Michele Battistel, Chin‐Chen Chang, Paul‐Emmanuel Vanderriele, Achille C. Pessina - Hypertension 2019 cited by 154

  20. Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 129

  21. Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eamonn R. Maher, Özgür Mete, Mitsuhide Naruse, Naris Nilubol, Mercedes Robledo, F. Sébag, Nalini S. Shah, Akiyo Tanabe, Geoffrey B. Thompson, Henri Timmers, J Widimský, William J. Young, Leah Meuter, Jacques W.M. Lenders, Karel Pacák - Nature Reviews Endocrinology 2023 cited by 90

  22. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma

    Authors: , , , , , , , , , , , , - Hypertension 2020 cited by 150

  23. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine

    Authors: , , - Nature Reviews Endocrinology 2014 cited by 482

  24. Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas

    Authors: , , , , , , , , , , , , , , , , , , - Cancer Research 2018 cited by 138